Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Transcranial direct current stimulation: benefits for treatment of primary progressive aphasia

Published on: 16/12/2016 Reading time: 1 min
aphp
Retour à la recherche

Transcranial direct current stimulation could be beneficial in treating primary progressive aphasia. This is what a pre-therapeutic study recently showed, conducted by teams led by Dr. Marc Teichmann, from the Pitié-Salpêtrière AP-HP Hospital neurology department, and Antoni Valero-Cabré, research director at the French Scientific Research Center (CNRS), both at Paris Brain Institute.

Primary progressive aphasia (PPA) is a degenerative illness characterized by progressive loss of language abilities. The most common form of PPA, known as “semantic”, is defined by progressive loss of the ability to process concepts and meaning of words.

Currently, there is no confirmed treatment for aphasia independently from its origin (degenerative or post-stroke). Studies up until now were conducted on small samples (often fewer than 6 patients) or individual case studies, complicating interpretation of results.

Dr. Marc Teichmann, from the Pitié-Salpêtrière AP-HP Hospital neurology department, and Antoni Valero-Cabré, research director at the French Scientific Research Center (CNRS), both at the Institut du Cerveau - ICM, coordinated a study of twelve patients with semantic PPA. Thorough double-blind placebo-controlled methodology allowed the evaluation of transcranial direct current simulation (tDCS) effects on language and semantic skills.
tDCS is a non-invasive stimulation involving low intensity direct current that flows thanks to two electrodes places on the scalp. It does not generate any specific sensation on the stimulated area, meaning that neither patients nor doctors can differentiate active stimulation from a placebo.

Short-term clinical effects of three kinds of stimulation (anterior left temporal cortex anodal excitation; anterior right temporal cortex cathodal inhibition; placebo stimulation) were evaluated during three sessions with a week in between each session. The effects of the three forms of stimulation were then compared.

Stimulation effect was evaluated using a multidimensional semantic test. Pre/post stimulation contrast analysis, which compared left and right tDCS to placebo stimulation, demonstrated several significant effects: improved verbal semantic performance function and improved function specifically for the “living things” category. A computational model, taking into account electrode location and conductivity of the various layers of tissue (from scalp to cerebral cortex), demonstrated optimized focality of the procedure on the anterior region of the temporal lobe and efficacy of the current delivered from the scalp to the targeted cortex.

It is noteworthy that tDCS is less costly and easier to use than other non-invasive brain modulation methods such as transcranial magnetic stimulation (TMS).
This pre-therapeutic study opens up new opportunities for developing clinical applications with more durable effects for patients with degenerative aphasia. A therapeutic protocol using repeated stimulation for 10 days to induce a months-long effect with neuroplasticity mechanisms was developed and recently received AP-HP promotion. If the procedure of consecutive stimulation for several days proves useful, it can be repeated as soon as benefits begin to decrease.

In the near future, treatments using stimulation could be tailored to cranial perimeters, lesion load and distribution of individual patients, to optimize stimulation for significant and durable therapeutic effects for everyone.

Sources

https://onlinelibrary.wiley.com/doi/10.1002/ana.24766/full
Teichmann M, Lesoil C, Godard J, Vernet M, Bertrand A, Levy R, Dubois B, Lemoine L, Truong DQ, Bikson M, Kas A, Valero-Cabré A. Ann Neurol. 2016 Sep 19.

Our news on the subject

Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
See all our news